Category Archives: IPR

Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer

Posted on April 27, 2021 by donttradeourlivesaway

If it turns out that the ICMR or the government owns the rights, the Indian public has the right to know how these were leveraged during a pandemic. Source: Scroll On Saturday, the pharmaceutical company Bharat Biotech officially announced the … Continue reading →

Posted in Access to Medecines, COVID-19, IPR, Patents, Vaccines | Tagged , , | Leave a comment

Activists urge Modi to reject India-US trade deal as it may hit access to affordable healthcare

Posted on September 21, 2019 by donttradeourlivesaway

Source: Live Mint 21st September 2019 The letter to the prime minister comes ahead of his visit to the US starting Sunday, where he is scheduled to meet US President Donald Trump NEW DELHI : A civil society group has written to Prime … Continue reading →

Posted in FTA, IP Rights, IPR, Trade Agreements, US-India FTA | Leave a comment

SCP 30: General statement of Knowledge Ecology International

Posted on June 26, 2019 by donttradeourlivesaway

Source: KEI 26th June, 2019   On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, … Continue reading →

Posted in Access to Medecines, IPR, Transparency | Leave a comment

Ingredients for WHO roadmap on access to medicines at civil society side event

Posted on May 29, 2018 by donttradeourlivesaway

Source: Intellectual Property Watch | May 25, 2018 On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the … Continue reading →

Posted in Access to Medecines, Cancer, IPR, TRIPS, WHO | Leave a comment

Why the US and pharmaceutical giants want a provision in India’s patent law revoked

Posted on May 7, 2018 by donttradeourlivesaway

Source: Scroll.in | May 02, 2018 India’s patent laws are under attack again. This time, too, the target is a provision not commonly found in patent laws elsewhere. This rule requires patent holders to disclose whether they are working their … Continue reading →

Posted in Generics, Indian Patent Law, IPR, Patents | Leave a comment

U.S. wants patent form recall

Posted on April 16, 2018 by donttradeourlivesaway

Source: The Hindu | April 15, 2018 Submission on interpretation of a domestic patent law raises eyebrows The United States Patent and Trademark Office (USPTO) has demanded the elimination of ‘Form 27’— a statutory requirement unique to India’s patent law … Continue reading →

Posted in Indian Patent Law, Indian Patent Office, IP Rights, IPR, Patent Enforcement, Patent infringement, US pressure on India | Leave a comment

MSF statement on resumption of EU-India FTA negotiations

Posted on April 11, 2018 by donttradeourlivesaway

Source: MSF Access Campaign | 11 April 2018 Officials from the European Union (EU) and India are expected to meet in Brussels on April 12th to resume technical talks on the long-stalled EU-India free trade agreement (FTA). A leaked draft … Continue reading →

Posted in EU-India FTA, IPR, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WTO | Leave a comment

EC publishes report on protection and enforcement of intellectual property rights in “third countries”

Posted on March 21, 2018 by donttradeourlivesaway

Source: Knowledge Ecology International   | March 14, 2018 On March 12, 2018, the European Commission published a report on the “protection and enforcement of intellectual property rights in third countries”. The main objective of the report “is to identify third countries … Continue reading →

Posted in IPR, Uncategorized | Leave a comment

The scalpels are out ahead of ‘Special 301’ Report

Posted on February 19, 2018 by donttradeourlivesaway

 by PT Jyothi Datta | The HinduBusinessLine Indian pharma pushes back against US trade body’s criticism of its IPR protection record For the past five years, a lone Indian pharmaceutical representation goes out to the Office of the US Trade … Continue reading →

Posted in IPR, Special 301 report, Uncategorized | Leave a comment

How Meaningful Is India’s Improved Ranking On Intellectual Property Index?

Posted on February 12, 2018 by donttradeourlivesaway

By Payaswini Upadhyay, Source: BloombergQuint | February 12, 2018 India’s ranking improved among 50 countries in the annual International IP Index this year on better protection for trademarks and copyrights and easier rules to patent computer-related innovations. The U.S. Chamber of Commerce … Continue reading →

Posted in IPR, Uncategorized | Leave a comment